These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33771529)

  • 1. Meeting Report: Psoriasis Stratification to Optimize Relevant Therapy Showcase.
    Yiu ZZN; Barker JNWN; Barnes MR; Di Meglio P; Emsley R; Reynolds NJ; Smith CH; Warren RB; Griffiths CEM;
    J Invest Dermatol; 2021 Aug; 141(8):1872-1878. PubMed ID: 33771529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress to Date in Advancing Stratified Medicine in Psoriasis.
    Reid C; Cordingley L; Warren RB; Griffiths CEM
    Am J Clin Dermatol; 2020 Oct; 21(5):619-626. PubMed ID: 32607944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis.
    Foulkes AC; Watson DS; Carr DF; Kenny JG; Slidel T; Parslew R; Pirmohamed M; ; Anders S; Reynolds NJ; Griffiths CEM; Warren RB; Barnes MR
    J Invest Dermatol; 2019 Jan; 139(1):100-107. PubMed ID: 30030151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the Psoriatic Microenvironment With Treatment Response.
    Wang G; Miao Y; Kim N; Sweren E; Kang S; Hu Z; Garza LA
    JAMA Dermatol; 2020 Oct; 156(10):1057-1065. PubMed ID: 32876657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting response to biologic treatment in psoriasis.
    Karczewski J; Poniedziałek B; Rzymski P; Adamski Z
    Dermatol Ther; 2014; 27(6):323-30. PubMed ID: 25053228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence Threshold for a Precision Medicine Test that Predicts Optimal Response to a Biologic Agent in Patients With Psoriasis: A Consensus Panel.
    Strober B; Fox J; Jekowsky E; Pariser D; Schaecher K
    J Drugs Dermatol; 2022 Jun; 21(6):630-636. PubMed ID: 35674756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current landscape of psoriasis genetics in 2020.
    Ogawa K; Okada Y
    J Dermatol Sci; 2020 Jul; 99(1):2-8. PubMed ID: 32536600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of immunogenicity of biologics in psoriasis: implications for treatment strategies.
    Carrascosa JM; van Doorn MB; Lahfa M; Nestle FO; Jullien D; Prinz JC
    J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1424-30. PubMed ID: 24841895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saudi practical guidelines on biologic treatment of psoriasis.
    Hamadah IR; Al Raddadi AA; Bahamdan KA; Fatani MI; Alnahdi A; Al Rakban AM; Alkhalifah A; Al Ameer A; Shaikh YH; Elgendi AM; Al Zoman AY; Alafif KA
    J Dermatolog Treat; 2015 Jun; 26(3):223-9. PubMed ID: 25075955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient-centred approach to biological treatment decision making for psoriasis: an expert consensus.
    Strohal R; Prinz JC; Girolomoni G; Nast A
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2390-8. PubMed ID: 26370908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of Complete Skin Clearance in Psoriasis as a Treatment Goal: Implications for Patient-Reported Outcomes.
    Blauvelt A; Wu JJ; Armstrong A; Menter A; Liu C; Jacobson A
    J Drugs Dermatol; 2020 May; 19(5):487-492. PubMed ID: 32484628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study.
    Warren RB; Marsden A; Tomenson B; Mason KJ; Soliman MM; Burden AD; Reynolds NJ; Stocken D; Emsley R; Griffiths CEM; Smith C;
    Br J Dermatol; 2019 May; 180(5):1069-1076. PubMed ID: 30155885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis.
    Ovejero-Benito MC; Muñoz-Aceituno E; Reolid A; Saiz-Rodríguez M; Abad-Santos F; Daudén E
    Am J Clin Dermatol; 2018 Apr; 19(2):209-222. PubMed ID: 28921458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term, real-world efficacy of biologics for psoriasis: a single centre's experience.
    Mercieca L; Lavery D; Warren RB; Griffiths CEM
    Br J Dermatol; 2019 Sep; 181(3):599-601. PubMed ID: 30738008
    [No Abstract]   [Full Text] [Related]  

  • 15. IL-20, IL-21 and p40: potential biomarkers of treatment response for ustekinumab.
    Gedebjerg A; Johansen C; Kragballe K; Iversen L
    Acta Derm Venereol; 2013 Mar; 93(2):150-5. PubMed ID: 22930279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies.
    Elyoussfi S; Thomas BJ; Ciurtin C
    Rheumatol Int; 2016 May; 36(5):603-12. PubMed ID: 26892034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational Research and Drug Development in Psoriasis by Collaborative Efforts of Academia and Industry.
    van de Kerkhof PCM
    J Invest Dermatol; 2020 Mar; 140(3):524-526. PubMed ID: 31945346
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
    Warren RB; Smith CH; Yiu ZZN; Ashcroft DM; Barker JNWN; Burden AD; Lunt M; McElhone K; Ormerod AD; Owen CM; Reynolds NJ; Griffiths CEM
    J Invest Dermatol; 2015 Nov; 135(11):2632-2640. PubMed ID: 26053050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concept of Remission in Chronic Plaque Psoriasis.
    Gisondi P; Di Mercurio M; Idolazzi L; Girolomoni G
    J Rheumatol Suppl; 2015 Nov; 93():57-60. PubMed ID: 26523059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of biotherapy used in psoriasis: the science behind the scenes.
    Jullien D; Prinz JC; Nestle FO
    J Invest Dermatol; 2015 Jan; 135(1):31-38. PubMed ID: 25120005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.